The Indian biotech and lifesciences industry recorded the fastest pace of growth in the last five years in 2010-11 to touch revenues of $4 billion (Rs 18,399.34 crore), according to a survey.
Of this, the biotech industry contributed Rs 17,249.34 crore, while the life science education market made up the remaining Rs 1,150 crore, according to the 9th annual BioSpectrum-Association of Biotechnology Led Enterprises (ABLE) survey.
The biotech industry, without the life sciences education component, recorded revenue growth of 21.5% vis-a-vis 2009-10 revenues of Rs 14,199 crore.
The top 10 South-based companies, led by Biocon, accounted for $1 billion (Rs 4816 crore) in revenues.
The contribution of the 'BioPharma', 'BioServices', 'BioAgri', 'Bioindustrials' and 'Bioinformatics' verticals was Rs 10,645 crore, Rs 3,245.97 crore, Rs 2,480 crore, Rs 626 crore and Rs 252 crore, respectively.
The BioPharma vertical contributed almost two-fifths of industry revenues, followed by BioServices with 18.82% and BioAgri with a 14.38% contribution. Bioindustrials and BioInformatics made up the rest of the industry revenue.
The fastest growing sector, BioAgri, has increased its market share in the last five years from less than 5% to over 14% of 2011 industry revenue.
